 In a subgroup analysis of the PA.03 study, patients developing a skin rash NCI CTC grade 2 had an advanced survival one-year-survival rate 43 vs. those with grade 1 or 0 one-year-survival rate 16 and 9, respectively. Later studies confirmed the correlation between skin rash and survival. 